BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31858611)

  • 1. Paeoniflorin: a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activities.
    Xiang Y; Zhang Q; Wei S; Huang C; Li Z; Gao Y
    J Pharm Pharmacol; 2020 Apr; 72(4):483-495. PubMed ID: 31858611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multifaceted mechanisms of Paeoniflorin in the treatment of tumors: State-of-the-Art.
    Wang XZ; Xia L; Zhang XY; Chen Q; Li X; Mou Y; Wang T; Zhang YN
    Biomed Pharmacother; 2022 May; 149():112800. PubMed ID: 35279012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paeoniflorin inhibits proliferation and induces apoptosis of human glioma cells via microRNA-16 upregulation and matrix metalloproteinase-9 downregulation.
    Li W; Qi Z; Wei Z; Liu S; Wang P; Chen Y; Zhao Y
    Mol Med Rep; 2015 Aug; 12(2):2735-40. PubMed ID: 25954855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling.
    Zheng YB; Xiao GC; Tong SL; Ding Y; Wang QS; Li SB; Hao ZN
    World J Gastroenterol; 2015 Jun; 21(23):7197-207. PubMed ID: 26109806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paeoniflorin inhibits proliferation and promotes apoptosis of multiple myeloma cells via its effects on microRNA‑29b and matrix metalloproteinase‑2.
    Wang S; Liu W
    Mol Med Rep; 2016 Sep; 14(3):2143-9. PubMed ID: 27430753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis.
    Hu S; Sun W; Wei W; Wang D; Jin J; Wu J; Chen J; Wu H; Wang Q
    Anticancer Drugs; 2013 Feb; 24(2):140-9. PubMed ID: 23069790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prolactin-release inhibitor paeoniflorin suppresses proliferation and induces apoptosis in prolactinoma cells via the mitochondria-dependent pathway.
    Wei Y; Zhou X; Ren L; Wang C; Li Y
    J Cell Biochem; 2018 Jul; 119(7):5704-5714. PubMed ID: 29388711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paeoniflorin inhibits the growth of bladder carcinoma via deactivation of STAT3.
    Yang J; Ren Y; Lou ZG; Wan X; Weng GB; Cen D
    Acta Pharm; 2018 Jun; 68(2):211-222. PubMed ID: 29702481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paeoniflorin suppresses pancreatic cancer cell growth by upregulating HTRA3 expression.
    Li Y; Gong L; Qi R; Sun Q; Xia X; He H; Ren J; Zhu O; Zhuo D
    Drug Des Devel Ther; 2017; 11():2481-2491. PubMed ID: 28860718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paeoniflorin inhibition of 6-hydroxydopamine-induced apoptosis in PC12 cells via suppressing reactive oxygen species-mediated PKCδ/NF-κB pathway.
    Dong H; Li R; Yu C; Xu T; Zhang X; Dong M
    Neuroscience; 2015 Jan; 285():70-80. PubMed ID: 25446358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paeoniflorin: A neuroprotective monoterpenoid glycoside with promising anti-depressive properties.
    Wang XL; Feng ST; Wang YT; Chen NH; Wang ZZ; Zhang Y
    Phytomedicine; 2021 Sep; 90():153669. PubMed ID: 34334273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies of paeoniflorin and albiflorin from Paeonia lactiflora on anti-inflammatory activities.
    Wang QS; Gao T; Cui YL; Gao LN; Jiang HL
    Pharm Biol; 2014 Sep; 52(9):1189-95. PubMed ID: 24646307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paeoniflorin Inhibits Migration- and Invasion-Promoting Capacities of Gastric Cancer Associated Fibroblasts.
    Wang ZF; Ma DG; Wang L; Feng L; Fu JW; Li Y; Wang DT; Jia YF
    Chin J Integr Med; 2019 Nov; 25(11):837-844. PubMed ID: 30361813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paeoniflorin inhibits proliferation and invasion of breast cancer cells through suppressing Notch-1 signaling pathway.
    Zhang Q; Yuan Y; Cui J; Xiao T; Jiang D
    Biomed Pharmacother; 2016 Mar; 78():197-203. PubMed ID: 26898442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems.
    Luan F; He X; Zeng N
    J Pharm Pharmacol; 2020 Nov; 72(11):1491-1512. PubMed ID: 32696989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paeoniflorin inhibits human glioma cells via STAT3 degradation by the ubiquitin-proteasome pathway.
    Nie XH; Ou-yang J; Xing Y; Li DY; Dong XY; Liu RE; Xu RX
    Drug Des Devel Ther; 2015; 9():5611-22. PubMed ID: 26508835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paeoniflorin inhibits cell growth and induces cell cycle arrest through inhibition of FoxM1 in colorectal cancer cells.
    Yue M; Li S; Yan G; Li C; Kang Z
    Cell Cycle; 2018; 17(2):240-249. PubMed ID: 29301438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paeoniflorin protects against intestinal ischemia/reperfusion by activating LKB1/AMPK and promoting autophagy.
    Wen J; Xu B; Sun Y; Lian M; Li Y; Lin Y; Chen D; Diao Y; Almoiliqy M; Wang L
    Pharmacol Res; 2019 Aug; 146():104308. PubMed ID: 31181335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paeoniflorin exerts antitumor effects by inactivating S phase kinase-associated protein 2 in glioma cells.
    Ouyang J; Xu H; Li M; Dai X; Fu F; Zhang X; Lan Q
    Oncol Rep; 2018 Mar; 39(3):1052-1062. PubMed ID: 29286139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of paeoniflorin on okadaic acid-induced tau hyperphosphorylation via calpain/Akt/GSK-3β pathway in SH-SY5Y cells.
    Ma XH; Duan WJ; Mo YS; Chen JL; Li S; Zhao W; Yang L; Mi SQ; Mao XL; Wang H; Wang Q
    Brain Res; 2018 Jul; 1690():1-11. PubMed ID: 29596798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.